| AVUYX | VVIAX | AVUYX / VVIAX | |
| Total Expense Ratio | 0.59 | 0.05 | 1,180% |
| Annual Report Gross Expense Ratio | 0.64 | 0.05 | 1,280% |
| Fund Existence | 9 years | 26 years | - |
| Gain YTD | 19.534 | 18.575 | 105% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.98B | 262B | 1% |
| Annual Yield % from dividends | 1.58 | 1.81 | 87% |
| Returns for 1 year | 14.89 | 23.77 | 63% |
| Returns for 3 years | 30.78 | 59.16 | 52% |
| Returns for 5 years | 9.74 | 60.13 | 16% |
| Returns for 10 years | N/A | 156.88 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ARMW | 40.42 | 1.66 | +4.30% |
| Roundhill ARM WeeklyPay ETF | |||
| XFLT | 19.45 | 0.48 | +2.53% |
| XAI Floating Rate & Alternative Income Trust | |||
| BUZZ | 37.59 | 0.20 | +0.53% |
| VanEck Social Sentiment ETF | |||
| TMNS | 49.62 | -0.01 | -0.02% |
| T. Rowe Price Short Municipal Income ETF | |||
| IHE | 104.68 | -0.74 | -0.70% |
| iShares US Pharmaceuticals ETF | |||